Floatz logo

Azacitidine

TP53 Gene Mutation

The University of Hong KongSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

5 Active assets in the TP53 Gene Mutation cohort.

Asset / SponsorPhaseRating
Decitabine
Northside Hospital, Inc.
Phase 2B
Cedazuridine
The University of Hong Kong
Phase 2CCC
Arsenic Trioxide
The University of Hong Kong
Phase 2CCC
Epirubicin
City of Hope Medical Center
Phase 1CC
Pembrolizumab
City of Hope Medical Center
Phase 1CC

Same molecule, other indications

Azacitidine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
73 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →